These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 2877851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1985 May 25; 290(6481):1535-8. PubMed ID: 2860942
    [Abstract] [Full Text] [Related]

  • 4. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
    van Hees PA, Bakker JH, van Tongeren JH.
    Gut; 1980 Jul 25; 21(7):632-5. PubMed ID: 6107263
    [Abstract] [Full Text] [Related]

  • 5. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA.
    Br J Rheumatol; 1995 Nov 25; 34 Suppl 2():16-9. PubMed ID: 8535642
    [Abstract] [Full Text] [Related]

  • 6. [Effect of 5-aminosalicylic acid as a constituent of sulfasalazine in the treatment of chronic polyarthritis].
    Wörth WD, Müller W.
    Z Rheumatol; 1986 Nov 25; 45(2):79-82. PubMed ID: 2873695
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.
    Garg GP, Cho CH, Ogle CW.
    Pharmacology; 1990 Nov 25; 40(6):318-24. PubMed ID: 1978355
    [Abstract] [Full Text] [Related]

  • 8. Active therapeutic moiety of sulphasalazine.
    van Hees PA, van Tongeren JH, Bakker JH, van Lier HJ.
    Lancet; 1978 Feb 04; 1(8058):277. PubMed ID: 74700
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U.
    Clin Pharmacokinet; 1985 Feb 04; 10(4):285-302. PubMed ID: 2864155
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.
    Farr M, Brodrick A, Bacon PA.
    Rheumatol Int; 1985 Feb 04; 5(6):247-51. PubMed ID: 2906452
    [Abstract] [Full Text] [Related]

  • 14. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H, Eisenburg J, Paumgartner G.
    Eur J Clin Pharmacol; 1984 Feb 04; 26(4):449-51. PubMed ID: 6428914
    [Abstract] [Full Text] [Related]

  • 15. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?
    Aruoma OI, Wasil M, Halliwell B, Hoey BM, Butler J.
    Biochem Pharmacol; 1987 Nov 01; 36(21):3739-42. PubMed ID: 2890355
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
    Rao SS, Cann PA, Holdsworth CD.
    Scand J Gastroenterol; 1987 Apr 01; 22(3):332-6. PubMed ID: 2884724
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
    Astbury C, Taggart AJ, Juby L, Zebouni L, Bird HA.
    Ann Rheum Dis; 1990 Aug 01; 49(8):587-90. PubMed ID: 1975737
    [Abstract] [Full Text] [Related]

  • 18. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T, Hunter JA, Capell HA.
    Br J Rheumatol; 1985 Aug 01; 24(3):269-76. PubMed ID: 2861876
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological and biochemical actions of sulphasalazine.
    Hoult JR.
    Drugs; 1986 Aug 01; 32 Suppl 1():18-26. PubMed ID: 2877850
    [Abstract] [Full Text] [Related]

  • 20. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action?
    Sheldon P, Webb C, Grindulis KA.
    Br J Rheumatol; 1988 Oct 01; 27(5):344-9. PubMed ID: 2902897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.